177 related articles for article (PubMed ID: 8223799)
41. Hyperprolactinemia after treatment of long-acting gonadotropin-releasing hormone analogue Decapeptyl in girls with central precocious puberty.
Kauschansky A; Nussinovitch M; Frydman M; Yeshaya A; Ben-Rafael Z
Fertil Steril; 1995 Aug; 64(2):285-7. PubMed ID: 7615104
[TBL] [Abstract][Full Text] [Related]
42. Effects on bone mineral density of gonadotropin releasing hormone analogs used in the treatment of central precocious puberty.
Unal O; Berberoğlu M; Evliyaoğlu O; Adiyaman P; Aycan Z; Ocal G
J Pediatr Endocrinol Metab; 2003 Mar; 16(3):407-11. PubMed ID: 12705366
[TBL] [Abstract][Full Text] [Related]
43. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
[TBL] [Abstract][Full Text] [Related]
44. Adult height in girls with idiopathic true precocious puberty.
Brauner R; Adan L; Malandry F; Zantleifer D
J Clin Endocrinol Metab; 1994 Aug; 79(2):415-20. PubMed ID: 8045957
[TBL] [Abstract][Full Text] [Related]
45. MANAGEMENT OF ENDOCRINE DISEASE: Long-term outcomes of the treatment of central precocious puberty.
Guaraldi F; Beccuti G; Gori D; Ghizzoni L
Eur J Endocrinol; 2016 Mar; 174(3):R79-87. PubMed ID: 26466612
[TBL] [Abstract][Full Text] [Related]
46. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
[TBL] [Abstract][Full Text] [Related]
47. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
Harris DA; Van Vliet G; Egli CA; Grumbach MM; Kaplan SL; Styne DM; Vainsel M
J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
[TBL] [Abstract][Full Text] [Related]
48. Serum sex hormone-binding globulin levels in healthy children and girls with precocious puberty before and during gonadotropin-releasing hormone agonist treatment.
Sørensen K; Andersson AM; Skakkebaek NE; Juul A
J Clin Endocrinol Metab; 2007 Aug; 92(8):3189-96. PubMed ID: 17519314
[TBL] [Abstract][Full Text] [Related]
49. [Long-term experiences with a long-acting gonadotropin releasing hormone analog in therapy of central precocious puberty: effect on body growth].
Hofmann-Ehrhart B; Schulz U; Kluge M; Wandl-Vergesslich K; Waldhauser F
Wien Klin Wochenschr; 1995; 107(14):413-7. PubMed ID: 7668000
[TBL] [Abstract][Full Text] [Related]
50. Diagnosis and treatment of central precocious puberty--can final height be improved? German/Dutch Central Precocious Puberty Study Group.
Sippell WG
Horm Res; 1994; 41 Suppl 2():14-5. PubMed ID: 8088698
[TBL] [Abstract][Full Text] [Related]
51. [Treatment of central precocious puberty with sustained-release triptorelin].
Boucekkine C; Blumberg-Tick J; Roger M; Thomas F; Chaussain JL
Arch Pediatr; 1994 Dec; 1(12):1127-37. PubMed ID: 7849900
[TBL] [Abstract][Full Text] [Related]
52. Secondary central precocious puberty in a girl with McCune-Albright syndrome responds to treatment with GnRH analogue.
Schmidt H; Kiess W
J Pediatr Endocrinol Metab; 1998; 11(1):77-81. PubMed ID: 9642633
[TBL] [Abstract][Full Text] [Related]
53. Precocious puberty associated with neurofibromatosis and optic gliomas. Treatment with luteinizing hormone releasing hormone analogue.
Laue L; Comite F; Hench K; Loriaux DL; Cutler GB; Pescovitz OH
Am J Dis Child; 1985 Nov; 139(11):1097-100. PubMed ID: 3933329
[TBL] [Abstract][Full Text] [Related]
54. Bone mineral density and body composition in Thai Precocious Puberty girls treated with GnRH agonist.
Wacharasindhu S; Petwijit T; Aroonparkmongkol S; Srivuthana S; Kingpetch K
J Med Assoc Thai; 2006 Aug; 89(8):1194-8. PubMed ID: 17048429
[TBL] [Abstract][Full Text] [Related]
55. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
Mansfield MJ; Beardsworth DE; Loughlin JS; Crawford JD; Bode HH; Rivier J; Vale W; Kushner DC; Crigler JF; Crowley WF
N Engl J Med; 1983 Nov; 309(21):1286-90. PubMed ID: 6415479
[TBL] [Abstract][Full Text] [Related]
56. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.
Manasco PK; Pescovitz OH; Feuillan PP; Hench KD; Barnes KM; Jones J; Hill SC; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1988 Aug; 67(2):368-72. PubMed ID: 3292562
[TBL] [Abstract][Full Text] [Related]
57. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H
Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254
[TBL] [Abstract][Full Text] [Related]
58. Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty.
Carel JC; Blumberg J; Seymour C; Adamsbaum C; Lahlou N;
Eur J Endocrinol; 2006 Jan; 154(1):119-24. PubMed ID: 16382000
[TBL] [Abstract][Full Text] [Related]
59. Effect of deslorelin dose in the treatment of central precocious puberty.
Pescovitz OH; Barnes KM; Cutler GB
J Clin Endocrinol Metab; 1991 Jan; 72(1):60-4. PubMed ID: 1898743
[TBL] [Abstract][Full Text] [Related]
60. [Treatment of central precocious puberty with Gonadotropin-Releasing Hormone agonist (triptorelin) in girls: breast development, skeletal maturation, height and weight evolution during and after treatment].
Messaaoui A; Massa G; Tenoutasse S; Heinrichs C
Rev Med Brux; 2005 Feb; 26(1):27-32. PubMed ID: 15816337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
